强大的金属氨酸过氧酸盐分解催化剂可以防止 doxorubicin 诱导的心脏功能障碍的发展
Pál Pacher1, Lucas Liaudet, Péter Bai
1Inotek Pharmaceuticals Corp, Beverly, Mass 01915, USA.
Circulation
|February 20, 2003
概括
氧酸盐有助于多克索鲁比 (DOX) 的心脏毒性. 一种新的催化剂FP15,通过向过氧酸,降低了DOX诱导的死亡率并改善了心脏功能,提供了潜在的心脏保护策略.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多克索鲁比 (DOX) 的心脏毒性与氧化应激和氧化失调有关.
- 过氧酸盐是一种反应性氧化剂,与心脏损伤有关.
- 研究了过氧酸盐在DOX诱导的心脏功能障碍中的作用.
研究的目的:
- 确定过氧酸盐在多克索鲁比诱导的心脏功能障碍中的病原性作用.
- 评估一种新的过氧酸分解催化剂 (FP15) 在减轻DOX心脏毒性的有效性.
- 探索过氧酸盐向作为心脏保护策略.
主要方法:
- 使用了DOX诱导的心脏功能障碍的动物模型.
- 小鼠接受多克索鲁比 (25毫克/公斤IP);评估心脏功能和死亡率.
- 治疗涉及过氧酸盐催化剂 (FP15),氧化合成酶抑制剂或淘汰小鼠.
- 测量了心脏损伤,氧化应激和DOX抗瘤作用的生物标志物.
主要成果:
- 服用DOX显著降低心脏功能,增加死亡率.
- FP15治疗和诱导性氧化合成酶基因删除改善了心脏功能和存活率.
- 抑制内皮氧化合成酶恶化了DOX诱导的死亡率.
- FP15降低了心脏损伤,脂质过氧化和酸铁氨酸形成的标志物,但没有影响DOX的抗瘤作用.
结论:
- 过氧酸盐在DOX诱导心脏毒性的病变发生过程中发挥着关键作用.
- 准过氧酸盐的形成是一个有前途的心脏保护方法后DOX暴露.
- 这种策略也可能有利于涉及过氧酸盐形成的条件,例如心肌缺血/反损伤.
相关概念视频
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...